# Moderna and Merck Revive mRNA Hopes With Melanoma Trial Success

https://mins.news/en/item/26437

- Bloomberg News, 2026-08-19 16:30 UTC
- Health
- Original: https://www.bloomberg.com/news/articles/2026-08-19/moderna-merck-mrna-shot-helped-cut-melanoma-recurrence-in-big-trial?link_source=ta_bluesky_link&taid=6a85da0fc69d29000181a213

> A personalized vaccine developed by Moderna and Merck reduced melanoma recurrence in a large late-stage trial. The result raises expectations for treating the deadliest form of skin cancer and highlights the potential of embattled mRNA technology.

## Related coverage

- [Merck and Moderna’s personalized cancer vaccine success opens new melanoma treatment avenue](https://mins.news/en/item/28563) — CNN, 2026-08-21
- [Moderna and Merck unveil mRNA cancer vaccine that cuts melanoma spread](https://mins.news/en/item/26640) — Al Jazeera, 2026-08-19
- [Merck, Moderna Melanoma Vaccine Study Succeeds](https://mins.news/en/video/26246) — Bloomberg Television, 2026-08-19